Shares surged 7.3% to $286.04 on September 25 as Bloom Energy's addition to the FTSE All-World Index capped a remarkable month that also saw the fuel-cell maker enter the S&P 500. The twin inclusions force index-tracking funds worldwide to buy the stock, creating a structural bid beneath a company whose price already reflects enormous expectations. The question now: Is there enough growth ahead to support a stock trading at roughly 365 times earnings?
Two Index Additions in a Month Create a Wave of Forced Buying
Bloom just moved into the FTSE All-World Index and the S&P 500 Equal Weighted Index after being dropped from a Russell small-cap benchmark, putting the stock in front of an entirely different group of institutional investors.
UBS estimates passive funds typically accumulate 25%–30% of a company's free-float market cap once it joins a major index, establishing a more stable ownership base. For a company with a market cap around $80.6 billion , that translates to billions in mandatory purchases — a powerful short-term support, though not a fundamental endorsement.
Record Revenue Shows AI Power Demand Is Real
Bloom reported record Q2 revenue of $1.065 billion, surpassing $1 billion for the first time, with 166% year-over-year growth driven by 215% product revenue growth.
Full-year 2026 guidance was raised to $3.9–$4.2 billion, with non-GAAP earnings per share expected at $2.55–$2.85.
CEO KR Sridhar said every major U.S. hyperscaler and more than a dozen AI labs have validated Bloom's on-site power solutions.
A $25 Billion Brookfield Deal Eases the Financing Burden
Brookfield Asset Management expanded its agreement to fund Bloom's AI-related power infrastructure to $25 billion, giving the company access to massive third-party project financing. That matters because building out gigawatts of fuel-cell capacity is capital-intensive; offloading the balance-sheet risk lets Bloom grow without drowning in debt.
The Bull Case Has Real Risks Attached
Analyst targets range from Jefferies at $229 to Mizuho at $351 — a $122 spread that illustrates how sharply Wall Street disagrees on the pace of AI power demand. Meanwhile, a securities fraud class action is active, with a September 28 lead plaintiff deadline, alleging misrepresentations during a period of rapid stock appreciation. At today's price, Bloom trades above the average analyst target of roughly $280, meaning any execution stumble — or a slowdown in data-center buildouts — could unwind gains fast.